BDSX (STOCKS)
Biodesix, Inc. Common Stock
$13.360000
+0.230000 (+1.75%)
Prev close: $13.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Scott Hutton
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $133.04M
- Employees
- 273
- P/E (TTM)
- -2.82
- P/B (TTM)
- -44.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.49 | $-0.87 | +0.3821 | +43.81% |
|
Sep 2025 (Q3)
|
$-1.16 | $-1.47 | +0.3088 | +21.02% |
|
Jun 2025 (Q2)
|
$-1.60 | $-1.39 | -0.2061 | -14.79% |
|
Mar 2025 (Q1)
|
$-1.60 | $-1.39 | -0.2128 | -15.34% |
Financial Statements
| Revenues | $88.50M |
| Benefits Costs and Expenses | $123.76M |
| Costs And Expenses | $123.76M |
| Nonoperating Income/Loss | -$7.39M |
| Operating Expenses | $116.37M |
| Selling, General, and Administrative Expenses | $87.55M |
| Depreciation and Amortization | $5.67M |
| Research and Development | $12.00M |
| Other Operating Expenses | $11.16M |
| Operating Income/Loss | -$27.87M |
| Income/Loss From Continuing Operations After Tax | -$35.27M |
| Income/Loss From Continuing Operations Before Tax | -$35.27M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $7.72M |
| Net Income/Loss | -$35.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$35.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $180.00K |
| Basic Earnings Per Share | -$4.67 |
| Diluted Earnings Per Share | -$4.67 |
| Basic Average Shares | 7,551,000 |
| Diluted Average Shares | 7,551,000 |
| Assets | $87.48M |
| Current Assets | $32.52M |
| Noncurrent Assets | $54.96M |
| Fixed Assets | $24.82M |
| Intangible Assets | $3.88M |
| Other Non-current Assets | $26.26M |
| Liabilities | $89.94M |
| Current Liabilities | $17.44M |
| Accounts Payable | $3.08M |
| Wages | $7.83M |
| Other Current Liabilities | $6.52M |
| Noncurrent Liabilities | $72.51M |
| Long-term Debt | $50.01M |
| Other Non-current Liabilities | $22.50M |
| Equity | -$2.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$2.47M |
| Liabilities And Equity | $87.48M |
| Net Cash Flow From Operating Activities | -$23.27M |
| Net Cash Flow From Operating Activities, Continuing | -$23.27M |
| Net Cash Flow From Investing Activities | -$403.00K |
| Net Cash Flow From Investing Activities, Continuing | -$403.00K |
| Net Cash Flow From Financing Activities | $16.42M |
| Net Cash Flow From Financing Activities, Continuing | $16.42M |
| Net Cash Flow | -$7.26M |
| Net Cash Flow, Continuing | -$7.26M |
| Comprehensive Income/Loss | -$35.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$35.27M |
| Other Comprehensive Income/Loss | $0.00 |